Blockchain Registration Transaction Record

Annovis Bio Names Hui Liu Director of Biostatistics for Phase 3 Alzheimer’s Trial

Annovis Bio appoints Hui Liu as Director of Biostatistics for Phase 3 Alzheimer’s trial, reinforcing data integrity and regulatory strategies for transformative neurodegenerative therapies.

Annovis Bio Names Hui Liu Director of Biostatistics for Phase 3 Alzheimer’s Trial

This news highlights the crucial role of Hui Liu in advancing Annovis Bio's mission to address neurodegeneration, potentially leading to groundbreaking treatments for patients suffering from Alzheimer's and Parkinson's diseases.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x42df871ce7942bad0e5ed1bf96bdb0cb6022eac791f6b36fd1be3df996dece56
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintnumbMRzp-2f3dcfa3f63b2405939b8b5773438a29